These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9670942)

  • 1. Qualitative differences between naive and memory T cells make a major contribution to the more rapid and efficient memory CD8+ T cell response.
    Kedl RM; Mescher MF
    J Immunol; 1998 Jul; 161(2):674-83. PubMed ID: 9670942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial.
    Cerwenka A; Morgan TM; Dutton RW
    J Immunol; 1999 Nov; 163(10):5535-43. PubMed ID: 10553081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen.
    Curtsinger JM; Lins DC; Mescher MF
    J Immunol; 1998 Apr; 160(7):3236-43. PubMed ID: 9531279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migration and activation of antigen-specific CD8+ T cells upon in vivo stimulation with allogeneic tumor.
    Kedl RM; Mescher MF
    J Immunol; 1997 Jul; 159(2):650-63. PubMed ID: 9218580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential requirement for CD4 help in the development of an antigen-specific CD8+ T cell response depending on the route of immunization.
    Bour H; Horvath C; Lurquin C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Jun; 160(11):5522-9. PubMed ID: 9605156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses.
    Ruby CE; Redmond WL; Haley D; Weinberg AD
    Eur J Immunol; 2007 Jan; 37(1):157-66. PubMed ID: 17183611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of naive and memory phenotypes on resting CD4 T cells in vivo.
    Boursalian TE; Bottomly K
    J Immunol; 1999 Jan; 162(1):9-16. PubMed ID: 9886364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant effect of IL-12: conversion of peptide antigen administration from tolerizing to immunizing for CD8+ T cells in vivo.
    Schmidt CS; Mescher MF
    J Immunol; 1999 Sep; 163(5):2561-7. PubMed ID: 10452994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characteristics and survival requirements of memory CD4+ T lymphocytes in vivo.
    London CA; Perez VL; Abbas AK
    J Immunol; 1999 Jan; 162(2):766-73. PubMed ID: 9916697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effector CD4 T cells are biochemically distinct from the memory subset: evidence for long-term persistence of effectors in vivo.
    Ahmadzadeh M; Hussain SF; Farber DL
    J Immunol; 1999 Sep; 163(6):3053-63. PubMed ID: 10477569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel approach to visualize polyclonal virus-specific CD8 T cells in vivo.
    Zimmermann C; Pircher H
    J Immunol; 1999 May; 162(9):5178-82. PubMed ID: 10227990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction and visualization of mucosal memory CD8 T cells following systemic virus infection.
    Kim SK; Schluns KS; Lefrançois L
    J Immunol; 1999 Oct; 163(8):4125-32. PubMed ID: 10510347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells.
    Wolint P; Betts MR; Koup RA; Oxenius A
    J Exp Med; 2004 Apr; 199(7):925-36. PubMed ID: 15051762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct phenotypes of antigen-selected CD8 T cells emerge at different stages of an in vivo immune response.
    Walker PR; Ohteki T; Lopez JA; MacDonald HR; Maryanski JL
    J Immunol; 1995 Oct; 155(7):3443-52. PubMed ID: 7561039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo.
    Grayson JM; Harrington LE; Lanier JG; Wherry EJ; Ahmed R
    J Immunol; 2002 Oct; 169(7):3760-70. PubMed ID: 12244170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice.
    Staveley-O'Carroll K; Schell TD; Jimenez M; Mylin LM; Tevethia MJ; Schoenberger SP; Tevethia SS
    J Immunol; 2003 Jul; 171(2):697-707. PubMed ID: 12847236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic administration of IL-15 augments the antigen-specific primary CD8+ T cell response following vaccination with peptide-pulsed dendritic cells.
    Rubinstein MP; Kadima AN; Salem ML; Nguyen CL; Gillanders WE; Cole DJ
    J Immunol; 2002 Nov; 169(9):4928-35. PubMed ID: 12391205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin.
    Masopust D; Vezys V; Usherwood EJ; Cauley LS; Olson S; Marzo AL; Ward RL; Woodland DL; Lefrançois L
    J Immunol; 2004 Apr; 172(8):4875-82. PubMed ID: 15067066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of CD8+ T cells undergoing primary and secondary responses to infection in the same host.
    Badovinac VP; Messingham KA; Hamilton SE; Harty JT
    J Immunol; 2003 May; 170(10):4933-42. PubMed ID: 12734336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.